Samuel George A. III 4
4 · Lineage Cell Therapeutics, Inc. · Filed Mar 8, 2024
Insider Transaction Report
Form 4
Samuel George A. III
General Counsel and Secretary
Transactions
- Award
Employee Stock Option (Right to Buy)
2024-03-07+650,000→ 650,000 totalExercise: $1.13Exp: 2034-03-07→ Common Shares (650,000 underlying)
Footnotes (1)
- [F1]One quarter of the options shall vest on March 7, 2025, and the balance shall vest in 36 monthly installments thereafter upon the completion of each month of continuous employment.